Advanced search×

New local hemostatic treatment for postpartum hemorrhage caused by placenta previa at cesarean section.

Acta Obstet Gynecol Scand 89(10):1346-9 (2010) PMID 20521867

Cesarean section in women with placenta previa is associated with the risk of heavy bleeding. We describe a new method where local hemostasis is obtained by applying a hemostatic fleece directly onto the lower uterine segment. During a 2-year period women undergoing cesarean section due to placenta previa were treated with this hemostatic fleece if they had ongoing bleeding during the surgical procedure despite routine treatment. Data were obtained retrospectively from the hospital records. Fifteen patients were treated by 15 different surgeons. No patients required reoperation. Three patients required blood transfusion due to anemia. No patients were readmitted to the hospital due to endometritis. We conclude that the application of a hemostatic fleece directly onto the bleeding surfaces in patients with post-cesarean bleeding due to placenta previa is technically unproblematic. The results suggest that this procedure should be considered in case of bleeding after delivery in women with placenta previa.

DOI: 10.3109/00016349.2010.485630
Version: za2963e q8za4 q8zb6 q8zce q8zda q8zec q8zf1 q8zga

Similar articles you may find interesting…

  1. Chronic pelvic pain in endometriosis: an overview.

    J Clin Med Res 5(3):153-63 (2013) PMID 23671540

    Chronic pelvic pain (CPP) could be considered nowadays a deep health problem that challenges physicians all over the world. This because its aetiology is still unclear, the course of the disease could vary a lot among different patients and through time in the same patient, and the r...
  2. Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis.

    Arthritis Rheum (2013) PMID 23653330

    Arthritis development is accompanied the changes in the expression of a number of epigenome-modifying enzymes. Drug-induced downregulation of the Aurora kinases, among other targets, seems to be sufficient to treat experimental arthritis. Development of new therapeutics that target the Aurora kinase...
  3. Children's Oncology Group's 2013 blueprint for research: Bone tumors

    Pediatr Blood Cancer 60(6):1009-1015 (2013) PMID 23255238

    In the US, approximately 650 children are diagnosed with osteosarcoma and Ewing sarcoma (ES) each year. Five-year survival ranges from 65% to 75% for localized disease and <30% for patients with metastases. Recent findings include interval-compressed five drug chemotherapy improves s...